NBMLHD clinicians helping support prevention research across NSW
Nepean Blue Mountains Local Health District is proud to announce that three of their leading researchers - Dr Kathryn Williams, Professor Shireen Meher and Associate Professor Emily Hibbert - are members of consortia that have been awarded Prevention Research Support Program (PRSP) funds by NSW Health.

The PRSP provides funding to NSW research organisations conducting prevention and early intervention research that aligns with NSW Health priorities. PRSP funding aims to support research, build research capability, and enable translation of evidence from research into policy and practice.
Dr Kathryn Williams is a member of the consortium which has been awarded funding from Stream 1: Embedding a population health and clinical preventive care approach to obesity and diabetes prevention and management in health service delivery, with an equity focus.
Professor Shireen Meher and Associate Professor Emily Hibbert are involved with Stream 3: Maternity and the first 2000 days, including preventive care, management of alcohol and substance use, and service interventions to prevent the primary causes of low birth weight. The consortium is led by Professor Dharmintra Pasupathy, Professor of Maternal & Fetal Medicine and Director of the Reproduction and Perinatal Centre at the Faculty of Medicine and Health, the University of Sydney.
Whilst the details of each of these projects are yet to be finalised, one very exciting aspect of this new approach is the broader collaboration of researchers from across the spectrum of the research community.
“The opportunity to work with world leading, established researchers on issues that we need to solve in our immediate community is priceless”, said Kathryn.
“This is an amazing opportunity to share what we are doing really well at NBMLHD and learn from more established research centres.”
According to Emily, "I am thrilled to be part of this consortium which stands to deliver tangible improvements in health care for women during pregnancy and for their offspring during the critical first 2000 days of development."